Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on pharmacotherapy for crack-cocaine dependence in the Netherlands
NL-OMON20300Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of topiramate, modafinil and dextroamphetamine in cocaine use disorder (CUD) (7 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Treatment retention and Cocaine use during 12-week study period. Started Apr 2010; status: active, not recruiting.
02
Drugs
topiramatemodafinildextroamphetamine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NL-OMON20300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20300.